Literature DB >> 12046855

Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis.

Paul Schwarzenberger1, Jay K Kolls.   

Abstract

Interleukin 17 (IL-17) is an essential proinflammatory T-cell derived cytokine with various biological actions. IL-17 was found to have a pivotal role in microbial host defense by interconnecting lymphoid and myeloid host defense. It also acts as a stimulatory hematopoietic cytokine by expanding myeloid progenitors and initiating proliferation of mature neutrophils. This article summarizes results to date on IL-17 research and discusses gene therapy based strategies that were employed to determine its biological functions and significance. A comprehensive working model for IL-17 is introduced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046855     DOI: 10.1002/jcb.10054

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  20 in total

1.  An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.

Authors:  Jeffrey J Yu; Matthew J Ruddy; Grace C Wong; Cornelia Sfintescu; Pamela J Baker; Jeffrey B Smith; Richard T Evans; Sarah L Gaffen
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

Review 2.  The role of Th17 cytokines in primary mucosal immunity.

Authors:  Jay K Kolls; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-20       Impact factor: 7.638

3.  Requirement of TPO/c-mpl for IL-17A-induced granulopoiesis and megakaryopoiesis.

Authors:  Weihong Tan; Bainan Liu; Adel Barsoum; Weitao Huang; Jay K Kolls; Paul Schwarzenberger
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

4.  Life before seventeen: cloning of the IL-17 receptor.

Authors:  Sarah L Gaffen
Journal:  J Immunol       Date:  2011-11-01       Impact factor: 5.422

5.  Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus.

Authors:  Jobert G Barin; Monica V Talor; Julie A Schaub; Nicola L Diny; Xuezhou Hou; Matthew Hoyer; Nathan K Archer; Elizabeth S Gebremariam; Meghan F Davis; Lloyd S Miller; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2016-07-26       Impact factor: 4.307

Review 6.  Targeting IL-17 and TH17 cells in chronic inflammation.

Authors:  Pierre Miossec; Jay K Kolls
Journal:  Nat Rev Drug Discov       Date:  2012-10       Impact factor: 84.694

7.  Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts.

Authors:  Akira Andoh; Hirofumi Yasui; Osamu Inatomi; Zhuobin Zhang; Yasuyuki Deguchi; Kazunori Hata; Yoshio Araki; Tomoyuki Tsujikawa; Katsuyuki Kitoh; Shokei Kim-Mitsuyama; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

Review 8.  The potential of interleukin-17 to mediate hematopoietic response.

Authors:  Aleksandra Krstic; Slavko Mojsilovic; Gordana Jovcic; Diana Bugarski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

9.  Colitis and colony-stimulating factors (CSFs): is stimulation of innate immunity through CSFs really effective for the treatment of chronic colitis?

Authors:  Kazuyoshi Nagayama; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

10.  Apical periodontitis and periodontal disease increase serum IL-17 levels in normoglycemic and diabetic rats.

Authors:  Luciano Tavares Angelo Cintra; Renata Oliveira Samuel; Mariane Maffei Azuma; Clícia Pereira Ribeiro; Luis Gustavo Narciso; Valéria Marçal Felix de Lima; Dóris Hissako Sumida; Gilberto Aparecido Coclete; Eloi Dezan-Júnior; João Eduardo Gomes-Filho
Journal:  Clin Oral Investig       Date:  2014-01-25       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.